Engineers Gate Manager’s Clovis Oncology, Inc. CLVS Stock Holding History

Engineers Gate Manager’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,406	Closed	-$16K	–	2140
2022 Q3	$16K	Sell	13,406 -16,186	-55%	-$25.2K	﹤0.01%	1542
2022 Q2	$53K	Buy	+29,592	New	+$43.7K	﹤0.01%	1786
2022 Q1	–	Sell	-16,779	Closed	-$45K	–	2482
2021 Q4	$45K	Buy	+16,779	New	+$62K	﹤0.01%	1881
2021 Q3	–	Sell	-40,300	Closed	-$234K	–	2099
2021 Q2	$234K	Buy	+40,300	New	+$236K	0.02%	1301
2020 Q4	–	Sell	-26,500	Closed	-$154K	–	2080
2020 Q3	$154K	Sell	26,500 -62,200	-70%	-$372K	0.01%	1482
2020 Q2	$599K	Buy	88,700 +71,178	+406%	+$539K	0.03%	858
2020 Q1	$111K	Buy	17,522 +6,722	+62%	+$53.9K	0.01%	1395
2019 Q4	$113K	Sell	10,800 -33,800	-76%	-$246K	0.01%	1533
2019 Q3	$175K	Buy	44,600 +29,634	+198%	+$240K	0.01%	1232
2019 Q2	$223K	Buy	+14,966	New	+$270K	0.01%	955

Other funds holding CLVS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Engineers Gate Manager's CLVS Position: Q4 2022 in Review

Engineers Gate Manager sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 13,406 shares — an estimated $16K sold.

Engineers Gate Manager first reported a position in CLVS in Q2 2019 and held it in 10 quarters. The position peaked at $599K in Q2 2020. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Engineers Gate Manager reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Engineers Gate Manager sold 13,406 Clovis Oncology, Inc. shares in Q4 2022, an estimated $16K.
Engineers Gate Manager first reported a position in Clovis Oncology, Inc. in Q2 2019 and held it in 10 quarters.
Engineers Gate Manager's Clovis Oncology, Inc. position peaked at $599K in Q2 2020.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Engineers Gate Manager's 13F filing for Q4 2022, filed 14 Feb 2023.